Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Birch Grove Capital
Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Birch Grove Capital
from 13F filings
Historical chart of Birch Grove Capital investment in Karyopharm Therapeutics Inc note 3.000%10/1
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Birch Grove Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Birch Grove Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.0B | 8.0M | 503.57 |
| 2023-09-30 | $5.2B | 8.0M | 651.88 |
| 2023-06-30 | $5.4B | 8.0M | 675.00 |
| 2023-03-31 | $7.8B | 10M | 781.92 |
| 2022-12-31 | $7.8M | 10M | 0.78 |
| 2022-09-30 | $8.1M | 10M | 0.81 |
| 2022-06-30 | $6.6M | 9.0M | 0.73 |
| 2022-03-31 | $7.5M | 9.0M | 0.84 |
| 2021-12-31 | $4.1M | 5.0M | 0.82 |
Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1
View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1